This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Omnicell (OMCL) Beats on Q3 Earnings, Raises '19 EPS View
by Zacks Equity Research
Omnicell (OMCL) continues to see solid segmental contributions in Q3. Expansion of gross and operating margins is a positive too.
Cerner (CERN) Earnings Beat Estimates in Q3, Improve Y/Y
by Zacks Equity Research
Cerner (CERN) Q3 results benefit from higher revenues, gains in Licensed software, Technology resale, Professional and Managed services units, and international revenue growth.
NextGen (NXGN) Q2 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
NextGen (NXGN) retains its fiscal 2020 revenue and EPS guidance.
GNC Holdings (GNC) Q3 Loss Meets Estimates, Revenues Miss
by Zacks Equity Research
GNC Holdings' (GNC) third-quarter 2019 results, reflecting dismal performance across segments, disappoint investors.
Illumina (ILMN) Beats Q3 Earnings Estimates, Raises View
by Zacks Equity Research
Illumina (ILMN) announces impressive Q3 results on the back of strong growth in the sequencing business.
The Zacks Analyst Blog Highlights: Walmart, AstraZeneca, Broadcom, Intuitive Surgical and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, AstraZeneca, Broadcom, Intuitive Surgical and Anthem
Medical Products Industry Outlook: Prospects Seem Promising
by Trina Mukherjee
Growth prospects look bright for the Zacks Medical Products industry, thanks to AI, Medical Mechatronics and Robotics and rampant M&As.
Intuitive Surgical (ISRG) Catches Eye: Stock Jumps 7%
by Zacks Equity Research
Intuitive Surgical (ISRG) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Top Research Reports for Walmart, AstraZeneca & Broadcom
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), AstraZeneca (AZN) and Broadcom (AVGO).
Intuitive Surgical (ISRG) Beats on Q3 Earnings, View Solid
by Zacks Equity Research
Intuitive Surgical (ISRG) gains from solid segmental contributions in Q3.
Here's Why You Should Retain Intuitive Surgical for Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction continues to raise concern.
What's in Store for Intuitive Surgical (ISRG) in Q3 Earnings?
by Zacks Equity Research
Better-than-expected performance at Instruments & Accessories segment and da Vinci procedure growth are likely to aided Intuitive Surgical (ISRG) in Q3 earnings.
Stocks & ETF to Invest in Healthcare Robotics and Innovation
by Neena Mishra
HTEC is poised to benefit from rapid advances in health-care technology
Stocks & ETF to Invest in Healthcare Robotics and Innovation
by Neena Mishra
HTEC is poised to benefit from rapid advances in health-care technology.
The Rise of Robots in Surgery Puts Spotlight on These 3 Stocks
by Zacks Equity Research
A number of MedTech companies are currently attempting to gain ground within the robotics-aided healthcare market.
Varian's ProBeam Now Available in Multi-Room Configuration
by Zacks Equity Research
Shandong Cancer Hospital in China selects Varian (VAR) to equip its new research center with the ProBeam Proton Therapy system.
Medidata (MDSO) Collaborates With Mapi Research to Boost Rave
by Zacks Equity Research
Medidata's (MDSO) latest collaboration is expected to solve major eCOA implementation struggles in the pharmaceutical industry.
Ecolab's (ECL) Nalco Water Opens Customer Experience Center
by Zacks Equity Research
Ecolab (ECL) expects Nalco's water technologies to reduce freshwater usage by 20%.
ETFs to Gain as Surgical Robots Rise in Popularity
by Sweta Jaiswal, FRM
We highlight ETFs which are set to gain from an expanding surgical robotic market on factors like growing demand for automation in healthcare, rising cases of chronic diseases and ageing population.
Here's Why You Should Invest in Intuitive Surgical (ISRG) Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base.
Aurora Cannabis (ACB) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Cannabis revenue growth and improved gross margin are likely to aid Aurora Cannabis (ACB) in Q4 earnings.
HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q2
by Zacks Equity Research
HealthEquity (HQY) gains from solid segmental contributions in second-quarter fiscal 2020.
What's in the Cards for HealthEquity (HQY) in Q2 Earnings?
by Zacks Equity Research
Higher revenues and possible margin expansion are likely to aid HealthEquity (HQY) in Q2 earnings.
Cooper Companies (COO) Q3 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Cooper Companies (COO) gains from solid segmental contributions in fiscal Q3.
Patterson Companies (PDCO) Earnings Beat Estimates in Q1
by Zacks Equity Research
Patterson Companies' (PDCO) Q1 results benefit from higher revenues, gross margin expansion, solid show by Corporate segment and lower expenses.